期刊文献+

可生物素化H-2K^d-BSP融合蛋白的原核表达和纯化 被引量:3

Purification and expression of H-2K^d-BSP fusion protein
暂未订购
导出
摘要 目的构建可生物素化的H-2Kd-BSP融合基因的表达载体,原核表达H-2Kd-BSP融合蛋白,以制备H-2Kd-肽四聚体。方法采用RT-PCR技术从小鼠SP2/0细胞中克隆小鼠MHC-Ⅰ类分子H-2Kd基因的胞外区,拼接上依赖BirA酶的可生物素化序列(BSP)后,插入pET-22b高效表达载体多克隆位点,诱导表达后对表达产物进行纯化,用Western印迹法分析鉴定纯化融合蛋白。结果成功构建pET-H-2Kd原核表达载体,测序证实H-2Kd-BSP融合基因序列正确。pET-H-2Kd原核表达载体可在大肠杆菌BL21中高效诱导表达H-2Kd-BSP融合蛋白,表达量占菌体总蛋白的36%,主要以包涵体形式表达;经反复洗涤纯化,纯化蛋白纯度可达90%以上。纯化蛋白可被H-2Kd分子特异性单克隆抗体SF1-1.1所识别。结论可生物素化H-2Kd-BSP融合蛋白的原核表达和纯化为进一步制备H-2Kd-肽四聚体奠定了实验基础。 Objective To obtain a recombinant H-2K^d-BSP fusion protein for preparing H- 2K^d-peptide tetramers to detect antigen-specific cytotoxic T lymphocytes (CTLs) in H-2K^d mouse. Methods The extracellular region of H-2K^d was cloned by RT-PCR from mouse SP2/0 cells, and added a 15 amino acid substrate peptide for BirA-dependent biotinylation to the COOH terminus of H-2K^d, then H-2K^d-BSP fusion gene was cloned into pET22b vector. Recombinant proteins of H- 2K^d-BSP were obtained by prokaryotic expression system. After purification, Western blot analysis was used to evaluate the expression of the fused protein. Results The fusion protein was successfully expressed in the form of inclusion body and amounted to over 36 % of total cell proteins via induction. After H-2K^d-BSP fusion protein was washed and purified, the final purity reached above 90 %. Furthermore, the fusion protein can be recognized by SFI-1.1, a monoclonal antibody-specific for H-2K^d molecule. Conclusions This work establishes a convenient approach for purification of large quantity of recombinant H-2K^d-BSP fusion protein and provides the basis for the preparation of H-2K^d tetramers to detect CTLs in H-2K^d mouse.
出处 《实用临床医药杂志》 CAS 2008年第4期1-4,共4页 Journal of Clinical Medicine in Practice
基金 国家自然科学基金项目(30771955) 江苏省自然科学基金基础研究重点项目(BK2006706)
关键词 H-2K^d H-2K^d—BSP融合蛋白 可生物素化序列 H-2K^d H-2Kd-BSP fusion protein BirA substrate peptide
  • 相关文献

参考文献6

  • 1Altman J D, Moss P A, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphoeytes[J]. Science, 1996, 274 (5284) : 94.
  • 2姜扬文,钱莉,龚卫娟,刘伟,蒋桂花,季明春.bcr-abl融合基因真核表达载体诱导小鼠特异性免疫应答[J].中华血液学杂志,2006,27(2):111-115. 被引量:2
  • 3姜扬文,钱莉,蒋桂花,刘伟,龚卫娟,季明春.bcr-abl基因疫苗对小鼠SP2/0/bcr-abl移植瘤的影响[J].中国实验血液学杂志,2006,14(4):800-803. 被引量:7
  • 4Schatz P J. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli[J]. Biotechnology, 1993, 11(10): 1138.
  • 5Janknecht R, de Martynoff G, Lou J, et al. Rapid and efficient purification of native histidine tagged protein expressed by recombinant vaccine virus [ J ]. Proc Natl Acad Scl USA, 1991, 88(20): 8972.
  • 6Kroll D J, Abdel-Hafiz H A, Marcell T, et al. A multifunction prokaryotic protein expression system: overproduction, affinity purification, and selective detection[J]. DNA Cell Biol, 1993, 12(5): 441.

二级参考文献10

  • 1姜扬文,钱莉,刘伟,龚卫娟,万兵,管俊,季明春.稳定表达bcr-abl融合基因片段的鼠SP2/0细胞系的建立[J].中国实验血液学杂志,2005,13(4):601-604. 被引量:4
  • 2Deininger MW,Goldman JM,Melo JV.The molecular biology of chronic myeloid leukemia.Blood,2000,96:3343-3356.
  • 3Schwartz J,Pinilla-Ibarz J,Yuan RR,et al.Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia.Semin Hematol,2003,40:87-96.
  • 4Cathcart K,Pinilla-Ibarz J,Korontsvit T,et al.A multivalent bcrabl fusion peptide vaccination trial in patients with chronic myeloid leukemia.Blood,2004,103:1037-1042.
  • 5Deininger MW,Goldman JM,Melo JV,et al.The molecular biology of chronic myeloid leukemia.Blood,2000;96:3343-3356
  • 6Schwartz J,Pinillba-Ibarz J,Yuan RR,et al.Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia.Semin Hematol,2003;40:87-96
  • 7Cathcara K,Pinilla-Ibarz J,Korontsvit T,et al.A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia.Blood,2004;103:1037-1042
  • 8Verfaillie CM,Mclvor RS,Zhao RC.Gene therapy for chronic myelogenous leukemia.Mol Med Today,1999;5:359-366
  • 9姜扬文,季明春,钱莉.Bcr-abl融合基因片段的克隆及在原核细胞中的融合表达[J].临床血液学杂志,2004,17(1):29-31. 被引量:3
  • 10姜扬文,季明春,钱莉,龚卫娟,万兵.慢性粒细胞白血病bcr-abl融合基因克隆与真核细胞表达的研究[J].江苏医药,2003,29(12):899-901. 被引量:7

共引文献7

同被引文献22

  • 1王丽珩,龚卫娟.人工抗原提呈细胞用于肿瘤免疫治疗的研究进展[J].国际生物制品学杂志,2006,29(5):212-215. 被引量:2
  • 2Condreay J P, Kost T A, Baculovlrus expression vectors for insect and mammalian cells[J]. Curr Drug Targets, 2007, 8 (10): 1126.
  • 3Kost T A, Condreay J P, Jarvis D L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells [J]. 2005, 23(5): 567.
  • 4Philipps B, Forsmer M, Mayr L M. A haculovirus expression vector system for simultaneous protein expression in insect and mammalian cells [J]. Biotechnol Prog, 2005, 21(3) : 708.
  • 5Kost T A, Condreay J P. Recombinant baculoviruses as mammalian cell gene - delivery vectors [ J ]. Trends Biotechnol, 2002, 20(4): 173.
  • 6Thompson J, Zimmerman W. The carcinoembryonie antigen family: structure, expression and evolution [ J ]. Tumor Biol, 1988,9 ( 2-3 ) : 63-83.
  • 7Mcaneny D,Ryan CA,Beazley RM,et al. Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer [ J ]. Ann Surg Oncol, 1996,3 ( 5 ) :495 -500.
  • 8Samanci A, Yi Q, Fagerberg J, et al. Pharmacological administration of granulocyte / macrophage - colony - stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcino- embryonic antigen [ J ] . Cancer Immunol Immunother, 1998,47 (3) :131-147.
  • 9Marshall JL, Hoyer R J, Toomey MA, et al. Phase I study in cancer patients of a diversified prime and boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses [ J ]. J Clin Oncol,2000,18 (23) :3964-3973.
  • 10van Mehren M, Arian R, Tsang KA,et al. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas [ J]. Clin Cancer Res, 2000,6 (6) :2219-2228.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部